Empagliflozin Improves HbA1c in Young People With T2DM
Significant reduction seen in HbA1c with empagliflozin, but not linagliptin, versus placebo
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Significant reduction seen in HbA1c with empagliflozin, but not linagliptin, versus placebo
Only registered members have full access to PracticeUpdate content.